A pharmacovigilance analysis of post-marketing safety of durvalumab

Abstract Durvalumab has demonstrated significant efficacy in several types of malignancies, while large-scale real-world safety studies remain limited. This study aimed to systematically evaluate the safety of durvalumab through data mining of the U.S. Food and Drug Administration Adverse Event Repo...

Full description

Saved in:
Bibliographic Details
Main Authors: An-Ju Tan, Wan-Ying Liu, Jun-Li Lu, Qing-Ying Tan, Yu Yan, Dun-Chang Mo
Format: Article
Language:English
Published: Nature Portfolio 2025-05-01
Series:Scientific Reports
Subjects:
Online Access:https://doi.org/10.1038/s41598-025-01583-1
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items